Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-19T06:38:13.465Z Has data issue: false hasContentIssue false
  • English
  • Français

A Protocol Approach to Assessing Medical Technologies

Published online by Cambridge University Press:  10 March 2009

Kathryn Lasch ,
Alesia Maltz ,
Frederick Mosteller  and
Tor Tosteson
Kathryn Lasch
Affiliation:
Yale University, Depression Research Unit
Alesia Maltz
Affiliation:
University of Illinois
Frederick Mosteller
Affiliation:
Harvard School of Public Health
Tor Tosteson
Affiliation:
Harvard School of Public Health
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 3 , Issue 1 , January 1987 , pp. 103 - 122
Copyright
Copyright © Cambridge University Press 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Behney, C. & Banta, D.Is medical technology safe? Hospitals, 53, (1 06 1979), 110–12.Google ScholarPubMed
2.Berk, A. & Chalmers, T.Cost and efficacy of the substitution of ambulatory for in-patient care. New England Journal of Medicine, 1981, 304, 393–97.CrossRefGoogle Scholar
3.Croog, S., Levine, S., Testa, M., Brown, B., Bulpitt, C., Jenkins, C., Klerman, G., & Williams, G.The effects of anti-hypertensive therapy on the quality of life. New England Journal of Medicine, 1986, 314, 1657–64.CrossRefGoogle Scholar
4.Committee for Evaluating Medical Technologies in Clinical Use, Institute of Medicine. Assessing Medical Technologies. Washington, DC: National Academy Press, 1985.Google Scholar
5.DerSimonian, R., Charette, L., McPeek, B., & Mosteller, F.Reporting of methods in clinical trials. New England Journal of Medicine, 1982, 306, 1332–37.CrossRefGoogle ScholarPubMed
6.Finkelstein, S., Isaacson, K., & Frishkoph, J.The process of evaluating medical technologies for third-party coverage. Journal of Health Care Technology, 1984, 1, 89–102.Google ScholarPubMed
7.Goddeeris, D. & Weisbrod, B.What don't we know about why health expenditures have soared. Center for Health Economics and Law Discussion Paper #214, University of Wisconsin, 1984.Google Scholar
8.Klerman, H. Observations on health care technology: measurement, analysis, and policy. In Altman, B. & Blendon, R. (eds.), Medical technology: the culprit behind health care costs?, U.S. DHHS No. (PHS) 79–3216, Washington, DC: Government Printing Office, 1979.Google Scholar
9.Lasch, K. Synthesizing in OHTA reports. Found summarized in Assessing Medical Technologies, Committee for Evaluating Medical Technologies in Clinical Use. Assessing Medical Technologies. Washington, DC: National Academy Press, 1985.Google Scholar
10.Luce, B.The implications of cost-effectiveness analysis of medical technology, Background paper #2: Case studies of medical technologies. Office of Technology Assessment, U.S. Congress, Washington, DC: General Printing Office, 1981.Google Scholar
11.Luft, H. Economic incentives and constraints in clinical practice. In Aiken, L. & Mechanic, D. (eds.), Applications of social science to clinical medicine and health policy. New Jersey: Rutgers University Press, 1986, 500–18.Google Scholar
12.Mosteller, F. et al. Reporting standards and research strategies for controlled trials. Controlled Clinical Trials, 1980, 1, 37–58.CrossRefGoogle Scholar
13. Needed for the age of DRGs: funding for quality-of-care and cost-effectiveness studies. Issues in Health Care Technology, 1986, Economics /1.10, ECRI.Google Scholar
14.Office of Health Technology Assessment. Public health procedures for evaluating health care technologies, 1983.Google Scholar
15.Office of Technology Assessment. Technology transfer at the National Institutes of Health: a technical memorandum. Washington, DC: Government Printing Office, 1982.Google Scholar
16.Office of Technology Assessment. Medical technology and costs of the Medicare program. Washington, DC: Government Printing Office, 1984.Google Scholar
17.Office of Technology Assessment. The impact of randomized clinical trials on health policy and medical practice. Washington, DC: U.S. Government Printing Office, 1985.Google Scholar
18.Philbrick, J.The limited spectrum of patients studied in exercise test research. Journal of the American Medical Association, 1982, 248, 2467–70.CrossRefGoogle ScholarPubMed
19.Schlesselman, J.Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982, 26.Google Scholar
20.U.S. DHHS, Public Health Service, Office of the Assistant Secretary of Health. Health Technology Assessment Reports, Vol. 3, 1983.Google Scholar
21.U.S. DHHS, Public Health Service, Office of the Assistant Secretory of Health. Health Technology Assessment Reports, Vol. 4, 1984.Google Scholar